NIS4 and NIS2+: Promising Blood-based Biomarkers for NASH Clinical Trials and Patient Care

Description

Supported by:  Labcorp

NIS4® is a blood-based test designed to effectively identify patients with at-risk metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH). The more recently developed NIS2+™ is an optimized version of NIS4® that was designed to improve score robustness. Both can be used for patient management and identification of subjects for MASH clinical trials.

Presenter:

Stephen A. Harrison, M.D.